サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1571897

遺伝性検査の世界市場

Hereditary Testing

出版日
ページ情報
英文 92 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
遺伝性検査の世界市場
出版日: 2024年10月18日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 92 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

遺伝性検査の世界市場は2030年までに118億米ドルに達する見込み

2023年に78億米ドルと推定される遺伝性検査の世界市場は、分析期間2023-2030年にCAGR 6.1％で成長し、2030年には118億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである着床前遺伝子診断・スクリーニング検査は、CAGR 6.9％を記録し、分析期間終了までに46億米ドルに達すると予測されます。非侵襲的出生前検査（NIPT）＆キャリアスクリーニング検査分野の成長率は、分析期間のCAGRで6.1％と推定されます。

米国市場は21億米ドルと推定・中国はCAGR 9.1%で成長予測

米国の遺伝性検査市場は2023年に21億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに27億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは9.1%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.3%と5.7%と予測されています。欧州では、ドイツがCAGR 3.8%で成長すると予測されています。

世界の遺伝性検査市場- 主要動向と促進要因のまとめ

遺伝性検査が個別化医療に革命をもたらす理由とは？

遺伝性検査は、遺伝性疾患や病態に関連する遺伝子変異の検出を可能にし、現代医療を変革するツールとなっています。遺伝性検査は、遺伝性疾患の診断、個別化治療計画の指導、遺伝的形質を子孫に残す潜在的リスクの患者への通知において、重要な役割を果たしています。遺伝性検査は、がんリスク評価、生殖医療、心血管疾患など、幅広い用途を網羅しています。遺伝子配列決定のコストが下がり続けるにつれて、遺伝性検査はより身近なものとなり、個人の健康状態に関する貴重な洞察を与え、早期介入や予防医療を可能にします。ゲノム科学の進歩により、遺伝性検査は今や個別化医療の礎となり、個人の遺伝子プロファイルに基づいたオーダーメイドのヘルスケアソリューションを提供しています。

技術の進歩は遺伝性検査市場をどのように拡大していますか？

遺伝性検査市場は、次世代シークエンシング（NGS）やポリメラーゼ連鎖反応（PCR）などの遺伝子シークエンシング技術の進歩によって大きく変化しました。これらの技術により、より迅速で正確、かつ費用対効果の高い遺伝子解析が可能になり、広範な遺伝子の変異の同定が容易になった。DTC（直接消費者向け）遺伝子検査キットの発展は、市場をさらに拡大し、個人がヘルスケアプロバイダーを介さずに遺伝性検査にアクセスできるようにしました。さらに、バイオインフォマティクスツールとAIの統合により、複雑な遺伝子データを解釈する能力が強化され、遺伝子と環境の相互作用や遺伝リスクに関するより深い洞察が得られるようになった。これらの技術革新はまた、出生前・着床前遺伝学的検査の精度と信頼性を向上させ、より安全な生殖医療の決定を保証しています。

市場セグメンテーションはどのように業界を形成しているか？

検査の種類には、予測検査、キャリア検査、出生前検査、新生児スクリーニングがあり、予測検査は、がんなどの遺伝性疾患の発症リスクの評価に広く使用されているため、最大のセグメントとなっています。遺伝性検査の用途は、腫瘍学、心臓病学、生殖医療、希少遺伝子疾患など多岐にわたる。腫瘍学は、特に乳がんや卵巣がんに関連するBRCA1/BRCA2変異の検出において最も重要な用途を占めています。最終用途セグメントには、病院、診断検査機関、消費者向け直接検査サービスが含まれ、診断検査機関はその高度な遺伝子検査能力とインフラにより最大のシェアを占めています。

遺伝性検査市場の成長を促進する要因は何か？

遺伝性検査市場の成長は、遺伝子疾患に対する意識の高まり、遺伝子配列決定の技術的進歩、個別化医療に対する需要の高まりなど、いくつかの要因によって牽引されています。病気の早期発見と予防のための遺伝子検査の重要性に対する消費者の意識の高まりが、遺伝性検査サービスの需要を促進しています。技術革新、特に次世代シーケンシング（NGS）は、遺伝性検査をより迅速、高精度、低価格にし、より多くの人々へのアクセスを拡大しました。個人の遺伝子プロファイルに基づいて治療計画を調整する個別化ヘルスケアソリューションへの注目の高まりが、市場の成長をさらに後押ししています。さらに、直接消費者に提供される遺伝子検査サービスの拡大により、遺伝性検査へのアクセスが民主化され、個人が遺伝的洞察に基づいて自分の健康を積極的に管理できるようになっています。

調査対象企業の例（注目の39社）

  • Agilent Technologies, Inc.
  • CENTOGENE N.V.
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd
  • Fulgent Genetic, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Medgenome
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Quest Diagnostics Incorporated
  • Sophia Genetics
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21952

Global Hereditary Testing Market to Reach US$11.8 Billion by 2030

The global market for Hereditary Testing estimated at US$7.8 Billion in the year 2023, is expected to reach US$11.8 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Preimplantation Genetic Diagnosis & Screening Test, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 9.1% CAGR

The Hereditary Testing market in the U.S. is estimated at US$2.1 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 9.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 5.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Global Hereditary Testing Market - Key Trends and Drivers Summarized

Why Is Hereditary Testing Revolutionizing Personalized Medicine?

Hereditary testing has become a transformative tool in modern medicine, enabling the detection of genetic mutations associated with inherited diseases and conditions. It plays a critical role in diagnosing genetic disorders, guiding personalized treatment plans, and informing patients of their potential risk of passing on genetic traits to their offspring. Hereditary testing encompasses a wide range of applications, including cancer risk assessment, reproductive health, and cardiovascular diseases. As the cost of genetic sequencing continues to decrease, hereditary testing has become more accessible, empowering individuals with valuable insights into their health and enabling early intervention or preventive care measures. With advancements in genomic science, hereditary testing is now a cornerstone of personalized medicine, providing tailored healthcare solutions based on individual genetic profiles.

How Are Technological Advancements Expanding the Hereditary Testing Market?

The hereditary testing market has been revolutionized by advancements in genetic sequencing technologies, such as next-generation sequencing (NGS) and polymerase chain reaction (PCR). These technologies allow for faster, more accurate, and cost-effective genetic analysis, making it easier to identify mutations across a broad range of genes. The development of direct-to-consumer (DTC) genetic testing kits has further expanded the market, enabling individuals to access hereditary testing without the need for a healthcare provider. Moreover, the integration of bioinformatics tools and AI has enhanced the ability to interpret complex genetic data, providing deeper insights into gene-environment interactions and hereditary risks. These innovations are also improving the accuracy and reliability of prenatal and preimplantation genetic testing, ensuring safer reproductive health decisions.

How Are Market Segments Shaping the Hereditary Testing Industry?

Test types include predictive testing, carrier testing, prenatal testing, and newborn screening, with predictive testing being the largest segment due to its widespread use in assessing the risk of developing inherited conditions such as cancer. Applications of hereditary testing range from oncology and cardiology to reproductive health and rare genetic disorders. Oncology represents the most significant application, particularly in detecting BRCA1/BRCA2 mutations linked to breast and ovarian cancers. The end-use segment includes hospitals, diagnostic laboratories, and direct-to-consumer testing services, with diagnostic laboratories holding the largest share due to their advanced genetic testing capabilities and infrastructure.

What Factors Are Driving the Growth in the Hereditary Testing Market?

The growth in the hereditary testing market is driven by several factors, including increasing awareness of genetic disorders, technological advancements in genetic sequencing, and the growing demand for personalized medicine. Rising awareness among consumers about the importance of genetic testing for early disease detection and prevention is fueling demand for hereditary testing services. Technological innovations, particularly in next-generation sequencing (NGS), have made hereditary testing faster, more accurate, and affordable, expanding its accessibility to a broader population. The growing focus on personalized healthcare solutions, where treatment plans are tailored based on individual genetic profiles, is further boosting market growth. Additionally, the expansion of direct-to-consumer genetic testing services has democratized access to hereditary testing, allowing individuals to proactively manage their health based on genetic insights.

Select Competitors (Total 39 Featured) -

  • Agilent Technologies, Inc.
  • CENTOGENE N.V.
  • CooperSurgical, Inc.
  • F. Hoffmann-La Roche Ltd
  • Fulgent Genetic, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Medgenome
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Quest Diagnostics Incorporated
  • Sophia Genetics
  • Thermo Fisher Scientific, Inc.
  • Twist Bioscience

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Hereditary Testing - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Genetic Disorders Drives Demand for Hereditary Testing
    • Technological Advancements in Genomic Sequencing Propel Growth in Hereditary Testing
    • Growing Focus on Personalized Medicine Expands Addressable Market for Genetic Testing
    • Increasing Awareness About Genetic Predisposition to Diseases Spurs Demand for Hereditary Testing
    • Expansion of Direct-to-Consumer (DTC) Genetic Testing Strengthens Business Case for Hereditary Testing Solutions
    • Rising Demand for Non-Invasive Prenatal Testing (NIPT) Drives Market Growth
    • Surge in Genetic Counseling Services Expands Opportunities for Hereditary Testing
    • Growing Use of Hereditary Testing in Oncology Drives Market Innovation
    • Increasing Focus on Early Disease Detection and Prevention Spurs Growth in Genetic Testing
    • Expansion of Telehealth Platforms Strengthens Access to Hereditary Testing Services
    • Technological Integration of AI and Big Data in Genomic Testing Expands Market Potential
    • Increasing Demand for Carrier Screening in Family Planning Drives Adoption of Hereditary Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Hereditary Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Hereditary Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Hereditary Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Preimplantation Genetic Diagnosis & Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Preimplantation Genetic Diagnosis & Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Preimplantation Genetic Diagnosis & Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Genetic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Genetic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Newborn Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Newborn Genetic Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Newborn Genetic Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Test Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Other Test Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Cytogenetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Cytogenetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 24: World 16-Year Perspective for Cytogenetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Biochemical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Biochemical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 27: World 16-Year Perspective for Biochemical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 28: World Hereditary Testing Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • JAPAN
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • CHINA
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • EUROPE
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hereditary Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hereditary Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Hereditary Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • FRANCE
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • GERMANY
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Spain 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Russia 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of Europe 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hereditary Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hereditary Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Hereditary Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Asia-Pacific 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Australia 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • INDIA
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: India 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: South Korea 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hereditary Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hereditary Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Hereditary Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Latin America 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Argentina 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Brazil 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Mexico 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Rest of Latin America 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hereditary Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hereditary Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Hereditary Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Middle East 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Iran 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Israel 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Saudi Arabia 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: UAE 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Rest of Middle East 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030
  • AFRICA
    • Hereditary Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hereditary Testing by Test Type - Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Hereditary Testing by Test Type - Percentage Breakdown of Value Sales for Preimplantation Genetic Diagnosis & Screening, Non-Invasive Prenatal Testing (NIPT) & Carrier Screening Tests, Genetic Tests, Newborn Genetic Screening and Other Test Types for the Years 2014, 2024 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hereditary Testing by Technology - Molecular, Cytogenetic and Biochemical Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Africa 16-Year Perspective for Hereditary Testing by Technology - Percentage Breakdown of Value Sales for Molecular, Cytogenetic and Biochemical for the Years 2014, 2024 & 2030

IV. COMPETITION